1: Senga T, Iwamoto S, Yoshida T, Yokota T, Adachi K, Azuma E, Hamaguchi M, Iwamoto T. LSSIG is a novel murine leukocyte-specific GPCR that is induced by the activation of STAT3. Blood. 2003 ;101(3):1185-7.
2: Yoshida T, Iwamoto T, Adachi K, Yokota T, Miyake Y, Hamaguchi M. Functional analysis of the effect of forced activation of STAT3 on M1 mouse leukemia cells. Int J Mol Med. 2005 ;15(2):269-75.
3: Yoshida T, Nakamura M, Miyake Y. Electrophysiological recovery after an ophthalmic artery occlusion during neurosurgery. Retina 2006 ;26(1):112-3.
4: Yoshida T, DeWan A, Zhang H, Sakamoto R, Okamoto H, Minami M, Obazawa M, Mizota A, Tanaka M, Saito Y, Takagi I, Hoh J, Iwata T. HTRA1 Promoter Polymorphism Predisposes Japanese to AMD. Mol Vis. 2007 13:545-8.
5: Yamada M, Yoshida J, Hatou S, Yoshida T, Minagawa Y. Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones. Br J Ophthalmol. 2008 ;92(6):848-51.
7: Guaiquil V, Swendeman S, Yoshida T, Chavala S, Campochiaro PA, Blobel CP. ADAM9 is involved in pathological retinal neovascularization. Mol Cell Biol. 2009 ;29(10):2694-703.
8: Usui S, Oveson BC, Lee SY, Jo YJ, Yoshida T, Miki A, Miki K, Iwase T, Lu L, Campochiaro PA. NADPH Oxidase Plays a Central Role in Cone Cell Death in Retinitis Pigmentosa. J Neurochem. 2009 ;110(3):1028-37.
10: Chi Z, Yoshida T, Lambris JD, Iwata T. Suppression of drusen formation by compstatin, a peptide inhibitor of complement C3 activation, on Cynomolgus monkey with early-onset macular degeneration. Adv Exp Med Biol. 2010;703:127-35
11: Tsubota K, Yoshida T, Kurosaka D, Lee RK, Alfonso EC, Nakazawa T. Miami to Japan eye-care rescue mission: vision van helps with relief efforts. Am J Ophthalmol. 2011 Nov;152(5):886-7.
英文原著論文原文
12: Shen J, Choy D , Yoshida T, Iwase T, Hafiz G, Do D, Rubio R, Nguyen Q, Hackett SF, Arron J, Shah S, Campochiaro PA Interleukin-18 has Anti-permeablity and Anti-angiogenic Activities in the Eye and is a Biomarker in Patients with Retinal Vein Occlusion submitted
13: Iwase T, Fu J, Yoshida T, Muramatsu D, Miki A, Hashida N, Oveson B, Nadri A, Shen J, Han B , Wu M , Semenza GL, Hanes J, Campochiaro PA Safe and Effective Polymeric-Doxorubicin Conjugate Nanoparticles for Prolonged Antiangiogenic Activity in the Eye submitted
1:Tsunehiko Yoshida Takashi Iwamoto Koichi Adachi Takashi Yokota Yozo Miyake Michinari Hamaguchi. Functional analysis of the effect of forced activation of STAT3 on M1 mouse leukemia cells. ELSO 2004 Meeting, September 7 2004 Nice
2:Takeshi Iwata, Shinsuke Umeda, Tsunehiko Yoshida, Michihiro T. Suzuki, Keiji Terao, Atsushi.Mizota, Yasuhiro Yoshikawa, YasuhikoTanaka, Yozo Miyake. Characterization of early and late onset forms of macular degeneration in cynomolgus monkey (Macaca fascicularis) 2006 ARVO Summer Eye Research Conference, July 9-12, 2006 Fort Myers, Florida
3: Takeshi Iwata,Tsunehiko Yoshida , Keiji Terao, Michihiro T. Suzuki, Atsushi.Mizota, Yasuhiro Yoshikawa, Yozo Miyake. Linkage Analysis of Early Onset Macular Degeneration in Cynomolgus Monkey with Complement Activated Drusen. XXI International Complement Workshop Oct 22-27, 2006 Beijing
4:Tsunehiko Yoshida , Kaoru Fujinami , Kei Shinoda , Yozo Miyake , Michihiro T. Suzuki, Keiji Terao , Yasuhiro Yoshikawa , Takeshi Iwata Focal Macular Electroretinogram of Cynomolgus Monkey (Macaca fascicularis) With Early Onset Macular Degeneration ARVO’s 2007 Annual Meeting, May 6, 2007 Fort Lauderdale, Florida.
5:Tsunehiko Yoshida, Andrew DeWan, Josephine Hoh, Takeshi Iwata HTRA1 Promoter Polymorphism Predisposes Japanese to AMD. Schepens International Society 2007 Meeting, October 25 2007 Washington DC
6:Asako Seki, Tsunehiko Yoshida, Shinsuke Umeda, Mitihiro Suzuki, Yasuhiro Yoshikawa and Takeshi Iwata Genomewide linkage survey of early-onset macular degeneration in a cynomolgus monkey (Macaca facicularis) pedigree ARVO’s 2008 Annual Meeting, April 29 , 2008 Fort Lauderdale, Florida.
7:Tsunehiko Yoshida, JiKui Shen, Christopher Seidel, Sean F. Hackett, Richard Lang, Peter A. Campochiaro Macrophage Ablation Suppresses Laser-Induced Choroidal Neovascularization (CNV) ARVO’s 2009 Annual Meeting, May 3, 2009 Fort Lauderdale, Florida.
8:Bing Xie, Aling Dong, Jikui Shen, Lili Lu, A. Rashid, Tsunehiko Yoshida, Sean F. Hackett, Peter A. Campochiaro .Id1 Deficiency Suppresses Ocular Neovascularization ARVO’s 2009 Annual Meeting, May 3, 2009 Fort Lauderdale, Florida.
9:Takeshi Iwata, Zai-Long Chi, Tsunehiko Yoshida, Kaoru Fujinami, Yozo Miyake, Atsushi Mizota Suppression of drusen formation by POT-4 a peptide inhibitor of complement component C3, on cynomolgus monkey with early-onset macular degeneration. Vision Research Conference, May 3 2009 Fort Lauderdale, Florida.
10:Takeshi Iwata, Zai-Long Chi, Tsunehiko Yoshida, Kaoru Fujinami, Yozo Miyake, Atsushi Mizota, Michihiro T. Suzuki, Keiji Terao , Yasuhiro Yoshikawa , JD. Lambris, and P. Olson. Suppression of drusen formation by Compstain (POT-4), a peptide inhibitor of complement component C3 Activation, on cynomolgus monkey with early-onset macular degeneration. First International Conference on Inflammation and Retinal Disease: Complement Biology and Pathology (Aegean Conference) June 2009 Crete Island, Greece.
11:Daisuke Muramatsu, Takeshi Iwase, Brian Oveson, Abdullah Nadri, Sun Young Lee, Tsunehiko Yoshida, Katsuaki Miki, Jude Samulski, Jade Samulski, Peter Campochiaro. Gene Transfer Of Bdnf Promotes Cone Survival And Function In A Model Of Retinitis Pigmentosa (RP) ARVO’s 2011 Annual Meeting, May 2, 2011 Fort Lauderdale
５：Yoshida T, Iwamoto T, Hamaguchi M. STAT3 activation is necessary, but not sufficient for terminal differentiation and cell growth arrest of M1 mouse leukemia cells. 第76回日本生化学会大会 2003年10月16日 横浜
